Rodman & Renshaw initiated coverage on INmune Bio Inc. (NASDAQ:INMB) with a Buy rating and set a price target of $23.00. The ...
While I love a classic cardigan that can compliment any outfit, I’m obsessed with this showstopping style from Free People ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback